<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Synergistic effect of β-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Pierluigi</forename><surname>Baron</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Daniela</forename><surname>Galimberti</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lucia</forename><surname>Meda</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elisabetta</forename><surname>Prat</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elio</forename><surname>Scarpini</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Giancarlo</forename><surname>Conti</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Maurizio</forename><surname>Moggio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alessandro</forename><surname>Prelle</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Guglielmo</forename><surname>Scarlato</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute of Neurology</orgName>
								<orgName type="institution" key="instit1">University of Milan</orgName>
								<orgName type="institution" key="instit2">IRCCS</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Institute of Ospedale Maggiore Policlinico</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Neurology</orgName>
								<orgName type="institution" key="instit2">University of Milan</orgName>
								<orgName type="institution" key="instit3">IRCCS Ospedale Maggiore Policlinico</orgName>
								<address>
									<addrLine>Via F. Sforza 35</addrLine>
									<postCode>20122</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Synergistic effect of β-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">8E775BD8C90DE65830B4C987BD7E59FC</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>nitric oxide</term>
					<term>β-amyloid</term>
					<term>muscle cell</term>
					<term>IBM</term>
					<term>apoptosis Aβ ϭ β-amyloid protein</term>
					<term>βAPP ϭ β-amyloid precursor protein</term>
					<term>s-IBM ϭ inclusion-body myositis</term>
					<term>h-IBM ϭ inclusion-body myopathy</term>
					<term>IFN-γ ϭ interferon gamma</term>
					<term>NO ϭ nitric oxide</term>
					<term>NOS ϭ nitric oxide synthase</term>
					<term>L-NMMA ϭ N ω -methyl-L-arginine</term>
					<term>DAPI ϭ 4Ј,6Ј-diamidino-2-phenylindole-dihydrochloride</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Nitric oxide (NO) is an important mediator of diverse physiological and pathological responses. NO-induced oxidative stress has been proposed in the pathogenesis of muscle tissue damage in inclusion-body myositis (IBM), which is characterized by deposition of β-amyloid protein (Aβ) in vacuolated muscle fibres. To determine whether Aβ can induce NO production in skeletal muscle, we stimulated C2C12 mouse skeletal muscle cells in vitro with Aβ[1-42] or Aβ[25-35] peptides in the presence or absence of interferon gamma (IFN-γ). Neither Aβ peptides nor IFN-γ were able to stimulate nitrite (NO 2 -) production by C2C12 cells when given alone. However, combination of IFN-γ with either Aβ[1-42] or Aβ[25-35] resulted</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Nitric oxide (NO) is a ubiquitous paracrine substance that is synthesized through the conversion of L-arginine to citrulline by catalytic action of the enzyme nitric oxide synthase (NOS). NOS has three major isoforms: neuronal, inducible and endothelial, each encoded by a different gene <ref type="bibr">(Dawson and Snyder, 1994;</ref><ref type="bibr" target="#b14">Forstermann et al., 1994;</ref><ref type="bibr">Nathan and Xie, 1994)</ref>. The inducible NOS (iNOS) is predominantly present in activated macrophages <ref type="bibr" target="#b34">(Stuehr et al., 1991)</ref>, but it can also be induced in various other cell types, including muscle cells <ref type="bibr" target="#b35">(Williams et al., 1994)</ref>.</p><p>NO has been the subject of numerous recent investigations documenting its role in the function of macrophages, the control of vascular tone by endothelial cells, and neurotrasmission and synaptic plasticity in neurons <ref type="bibr" target="#b10">(Dawson and Dawson, 1994)</ref>. Even though NO can act as an intracellular second messenger in various cells and tissues, excessive synthesis of NO can induce oxidative stress via combination with superoxide (O 2 -) to produce highly toxic peroxynitrite (ONOO -) <ref type="bibr" target="#b7">(Blough and Zafiriou, 1985)</ref>.</p><formula xml:id="formula_0">©</formula><p>Excessive production of NO has been postulated to play an important pathogenic role in various diseases, including Alzheimer's disease and in sporadic and hereditary forms of muscle disease called inclusion-body myositis (s-IBM) and myopathy (h-IBM) <ref type="bibr" target="#b17">(Good et al., 1996;</ref><ref type="bibr" target="#b37">Yang et al., 1996</ref><ref type="bibr" target="#b38">Yang et al., , 1998;;</ref><ref type="bibr" target="#b33">Smith et al., 1997)</ref>. These conditions share pathological abnormalities, because senile plaques in Alzheimer's disease as well as vacuolated muscle fibres in IBM contain a unique combination of proteins, including β-amyloid protein (Aβ), which is a 39-to 42-residue polypeptide derived from the cleavage of a large precursor protein (βAPP) <ref type="bibr">(Askanas et al., 1992a, b;</ref><ref type="bibr">Gambetti and Perry, 1994)</ref>.</p><p>The mechanisms leading to oxidative stress in both Alzheimer's disease and IBM are still not well defined, but because abnormal accumulation of Aβ occurs very early in the disease processes and precedes other abormalities, it is currently believed that Aβ deposition is a crucial event in the pathogenesis of either senile plaques in Alzheimer's disease or vacuolated muscle fibres in both s-IBM and h-IBM <ref type="bibr" target="#b23">(Maury, 1995;</ref><ref type="bibr" target="#b38">Yang et al., 1998)</ref>. Even though Alzheimer's disease brain contains extracellular deposits of Aβ, which instead are intracellular in IBM, the presence in pathological muscle fibres of Aβ fibrils with the same features as those of senile plaques raises the question of whether Aβ deposition may trigger a similar response from different cell types.</p><p>Previous studies have shown that a variety of Aβ peptides, in the presence of interferon gamma (IFN-γ), can activate microglia with production of free radicals potentially involved in neurodegeneration associated with Alzheimer's disease <ref type="bibr" target="#b18">(Goodwin et al., 1995;</ref><ref type="bibr" target="#b25">Meda et al., 1995</ref><ref type="bibr" target="#b24">Meda et al., , 1996))</ref>. Drawing from these reports, in the present study we investigated whether Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> and Aβ[1-42] peptides, together with IFN-γ, can also trigger NO 2 -production from cultured muscle cells as they do for microglia in vitro. We have approached this issue using C2C12 cells, which are an extensively studied skeletal myoblast cell line derived from the hindlimb of normal mice <ref type="bibr" target="#b36">(Yaffe and Saxel, 1977)</ref>. Our data demonstrate that Aβ plus IFN-γ trigger NO 2 -production by skeletal muscle cells via induction of iNOS gene expression. We also provide evidence for occasional apoptotic morphology in Aβ/IFN-γ-stimulated C2C12 myogenic cells. These data further support a role for Aβ deposition in the pathogenesis of postulated oxidative damage in IBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and methods Material</head><p>Aβ  and  peptides (Bachem, Hannover, Germany) were resuspended in sterile H 2 O, at a concentration of 1 mg/ml, and kept at -20°C. Recombinant murine IFN-γ and N ω -methyl-L-arginine (L-NMMA) were purchased from Sigma Chemical Company (St Louis, Mo., USA). IFN-γ was resuspended in PBS (phosphate buffered saline) supplemented with 1% foetal bovine serum (Gibco-BRL, Bethesda, Md., USA), while L-NMMA was suspended in sterile H 2 O.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Muscle cell cultures</head><p>C2C12 murine cell line was provided by the European Collection of Animal Cell Cultures (ECACC). Cells were plated in 96-well plates at a concentration of 1 ϫ 10 4 /100 µl/well or in six-well plates at a concentration of 1 ϫ 10 6 / ml/well, and cultured in DMEM (Dulbecco's modified Eagle's medium) with 5% glucose (Gibco-BRL), supplemented with 10% heat-inactivated foetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin (Sigma). After incubation with culture stimuli for the indicated times, cell-free supernatants were collected and stored at -70°C for subsequent assays. Total RNA was extracted from adherent cells cultured in six-well plates.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nitrite assay</head><p>Nitrite (NO 2 -) is a stable end-product used extensively as an indicator of NO production by cultured cells. In our experimental conditions, NO 2 -accumulation was assayed by the Griess reaction, according to the method described previously <ref type="bibr" target="#b31">(Rockett et al., 1992)</ref>. Briefly, cell-free supernatants were mixed with equal amounts of Griess reagent (p-aminobenzene sulfonilamide 1%, naphtylethylenediamide 0.1% in phosphoric acid 2.5%) in 96-well plates. Samples were incubated at room temperature for 10 min, and subsequently absorbance was read at 540 nm using a microplate reader. NO 2 -concentrations were calculated in accordance with a sodium nitrite standard curve.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA extraction and Northern blot analysis</head><p>C2C12 muscle cells were plated in six-well plates at a concentration of 1 ϫ 10 6 /ml/well and then incubated with stimuli. At the indicated times, total RNA was extracted and analysed as described previously <ref type="bibr" target="#b24">(Meda et al., 1996)</ref>. The cDNA fragments encoding mouse macrophage iNOS <ref type="bibr" target="#b22">(Lyons et al., 1992)</ref> were labelled with 32 P using a Ready-To-Go labelling kit (Pharmacia, Uppsala, Sweden) before hybridization of nylon filters and autoradiography. Blots were subsequently rehybridized with a human G3PDH (glyceraldehyde-3-phosphate dehydrogenase) cDNA probe (Clontech Laboratories Inc., Palo Alto, Calif., USA) as an internal control.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data are expressed as means Ϯ standard deviations. Statistical evaluation was performed by repeated measures ANOVA (analysis of variance) followed by Dunnet's test for specific comparisons. Statistical significance was set at P Ͻ 0.05.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nuclear morphology</head><p>Nuclear morphology was examined by staining C2C12 cells with 2 mg/ml DAPI (4Ј,6Ј-diamidino-2-phenylindoledihydrochloride) (Boehringer Mannheim, GmbH, Germany). To estimate the number of cells that fulfilled the morphological (DAPI) criteria of apoptosis, at least 300 nuclei were counted from three coverslips and results were expressed as the ratio of fragmented nuclei to total nuclei ϫ 100.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Electron microscopy</head><p>C2C12 muscle cells, after incubation with stimuli for the indicated times, were fixed in glutaraldehyde in PBS and post-fixed in 1% osmium tetroxide in the same buffer. They were then dehydrated and embedded in epoxy resin as described previously <ref type="bibr" target="#b28">(Moggio et al., 1989)</ref>. Thin sections were stained with uranyl acetate and lead citrate and examined with Zeiss EM 109 electron microscope.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>To determine whether Aβ can induce NO 2 -production by skeletal muscle in vitro, C2C12 cells were stimulated with Aβ  or Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref>. These peptides at concentrations up to 100 µg/ml, as well as IFN-γ 100 U/ml, used alone, did not trigger statistically significant NO 2 -release during 72 h stimulation. However, when Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> or Aβ[1-42] was combined with IFN-γ, accumulation of NO 2 -was detected after 48 h in cell free supernatants (16 Ϯ 2-and 12 Ϯ 2.8-fold increase over control for  and Aβ[1-42], respectively; P Ͻ 0.05, n ϭ 5) (Fig. <ref type="figure" target="#fig_1">1</ref>). Dose-response studies demonstrated that the amount of NO 2 -released into the culture medium was related to increasing concentrations of Aβ  or Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> (Fig. <ref type="figure" target="#fig_2">2</ref>). In additional experiments, release of NO 2 -triggered by Aβ peptides plus IFN-γ was inhibited by 88% using 100 µM L-NMMA, a specific inhibitor of iNOS activity (not shown). Specificity of the effect of Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> was demonstrated by using a scrambled analogue, which failed to induce NO 2 -production over that triggered by IFN-γ alone (Fig. <ref type="figure" target="#fig_3">3</ref>). Stimulation of C2C12 myoblasts and differentiated myotubes with Aβ peptides and IFN-γ resulted in statistically indistinguishable NO 2 -levels in cellfree supernatants, demonstrating that the stage of differentiation did not affect the ability of C2C12 cells to produce NO 2 -(Fig. <ref type="figure" target="#fig_4">4</ref>). To investigate whether the production of NO 2 -triggered by Aβ peptides in the presence of IFN-γ reflected induction of iNOS gene expression, Northern blot analysis was performed on C2C12 total RNA, using a probe complementary to the mouse macrophage iNOS coding sequence. In resting conditions as well as after incubation with individual IFN-γ or Aβ peptides, the mRNA expression for iNOS in C2C12 cells was absent. Steady-state mRNA levels of iNOS were clearly increased after stimulation of the cells with Aβ or Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> at the concentration of 50 µg/ml, in the presence of IFN-γ (100 U/ml) (Fig. <ref type="figure" target="#fig_5">5</ref>).</p><p>Finally, to detect the presence of apoptotic morphology of C2C12 cells upon incubation with Aβ and IFN-γ, muscle cultures were examined by DAPI staining and electron microscopy. As shown in Fig. <ref type="figure" target="#fig_6">6</ref>, ~4% of muscle cells showed morphological evidence of apoptosis after exposure to Aβ plus IFN-γ for 48 h.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In this study we demonstrate that Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> and Aβ[1-42] peptides, in the presence of IFN-γ, are able to induce the production of NO 2 -by cultured murine C2C12 cells. Similar NO 2 -levels were obtained in cell-free supernatants from C2C12 myoblasts and differentiated myotubes, showing that the stage of differentiation did not affect the ability of C2C12 cells to release NO 2 -in response to Aβ peptides plus IFNγ. The effect of Aβ and IFN-γ on NO 2 -production was regulated at the level of mRNA accumulation, as indicated by increased expression of iNOS mRNA in Aβ/IFN-γstimulated C2C12 myogenic cells, and it was obtained with both Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> and the full-length Aβ . Moreover, L-NMMA, a specific inhibitor of iNOS activity, almost completely suppressed NO 2 -production triggered by Aβ peptides plus IFN-γ. Specificity of the effects of Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> was demonstrated using a peptide with the same amino acid composition as Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref>, but with a scrambled sequence, which did not influence NO 2 -accumulation by C2C12 cells treated with IFN-γ.</p><p>Production of NO 2 -by C2C12 skeletal muscle cells stimulated with  or Aβ , in the presence of IFN-γ, although ~30% lower, was in the same range of concentrations of those observed in microglial cells under similar experimental conditions <ref type="bibr" target="#b18">(Goodwin et al., 1995;</ref><ref type="bibr" target="#b25">Meda et al., 1995;</ref><ref type="bibr" target="#b33">Smith et al., 1997)</ref>. However, while IFN-γ alone has been shown to be a stimulus for NO 2 -accumulation in microglia, it was incapable of inducing NO 2 -release in C2C12 cells by itself, even though it appeared to be a necessary component for the biological effect of Aβ peptides. The possible explanations for the essential role of IFN-γ in NO 2 -release and induction of iNOS mRNA in C2C12 muscle cells include upregulation of an as yet undiscovered receptor for Aβ protein, activation of intracellular signalling pathways, or co-induction of necessary transcription factors.</p><p>The results of our study suggest that NO production triggered by Aβ and IFN-γ might have manifold consequences for the pathophysiology of skeletal muscle and is important on several accounts. NO has been shown to inhibit muscle contractility through a cGMP dependent mechanism <ref type="bibr" target="#b21">(Kobzik et al., 1994)</ref> and to decrease basal glucose transport into skeletal muscle <ref type="bibr" target="#b6">(Balon and Nadler, 1994)</ref>. Moreover, NO -production by C2C12 cells. C2C12 cells were cultured in 96-well plates and stimulated with increasing concentrations of Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> or Aβ  in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of three performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown. -production by C2C12 cells. C2C12 cells were cultured in 96-well plates and stimulated with  or Aβ <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref><ref type="bibr">[33]</ref><ref type="bibr">[34]</ref><ref type="bibr">[35]</ref> scrambled 50 µg/ml in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of three performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown. can combine with O 2 -to produce highly toxic ONOO -, which in turn may induce aberrant protein nitration <ref type="bibr" target="#b38">(Yang et al., 1998)</ref> and damage to the muscle cell surface. NO, because of its lipophilic properties, can then readily diffuse into the extracellular milieu to react with surrounding structures and cells <ref type="bibr">(Brown, 1995)</ref>. Finally, NO can mediate toxic effects of cytokines, playing a pathophysiological role during the acute and chronic phases of inflammatory reactions <ref type="bibr" target="#b35">(Williams et al., 1994)</ref>.</p><p>The significance of Aβ deposits in IBM represents a subject of debate. The intracellular location of IBM-associated Aβ favours a protein synthesized within the cell. However, whether it represents an altered protein derived from a normal gene product or an isoform of a normal protein resulting from a gene mutation is presently unknown <ref type="bibr">(Mendell et al.,</ref>  1991). Regardless of the source of Aβ in IBM, the potential importance of Aβ deposition and oxidative damage in human muscle pathology is supported by several findings. First, abnormal accumulation of Aβ in IBM often precedes other abnormalities, including congophilia and vacuolization <ref type="bibr" target="#b3">(Askanas et al., 1992b;</ref><ref type="bibr" target="#b32">Sarkozi et al., 1994)</ref>. Secondly, direct transfer of the βAPP gene into cultured normal muscle cells is sufficient to induce several of the typical morphological aspects of IBM <ref type="bibr" target="#b4">(Askanas et al., 1996</ref><ref type="bibr" target="#b5">(Askanas et al., , 1997))</ref>. Thirdly, iNOS immunoreactivity is detectable in vacuolated muscle fibres and co-localizes with Aβ deposition in both s-IBM and h-IBM <ref type="bibr" target="#b38">(Yang et al., 1998)</ref>. Therefore, our data suggest that the synergistic effect of Aβ and IFN-γ on NO production from C2C12 muscle cells in culture might be at least partly responsible for the increase of iNOS in vacuolated fibres of IBM. However, since Aβ acted synergistically with IFN-γ, a question raised by our study is the pathophysiological role of IFN-γ in vivo in s-IBM and h-IBM. Because sIBM is characterized by varying degrees of inflammation <ref type="bibr" target="#b20">(Karpati and Carpenter, 1993;</ref><ref type="bibr" target="#b27">Mikol and Engel, 1994)</ref>, the presence of CD8ϩ cytotoxic T cells and macrophages might be a potential source of IFN-γ. The lack of lymphocytic inflammation in h-IBM <ref type="bibr">(Askanas and Engel, 1993</ref>) makes more intringuing the role of IFN-γ in this condition. Future studies will address whether other molecules besides IFN-γ, for example products of muscle catabolism, may cooperate with Aβ in mediating its biological effects in h-IBM.</p><p>We also provide evidence that incubation of C2C12 muscle cultures with Aβ and IFN-γ induces ultrastructural nuclear abnormalities such as irregular clusters of condensed chromatin, suggesting the presence of apoptotic morphology. However, since these features were only occasionally detectable in our culture conditions, we do not have sufficient data to support the idea that apoptosis may be a relevant mode of muscle cell death related to NO production driven by Aβ and IFN-γ stimulation. This notion is also in agreement with the lack of typical apoptotic changes in IBM, even though some muscle fibres have been found to express the oncoprotein <ref type="bibr">Bcl-2 (Figarella-Branger et al., 1988)</ref>, which is an inhibitor of apoptosis and whose expression has been considered to be an attempt to escape programmed cell death <ref type="bibr" target="#b19">(Hockenbery et al., 1990)</ref>.</p><p>In conclusion, our study demonstrates that the combination of Aβ peptides plus IFN-γ induces production of NO 2 -and accumulation of iNOS mRNA from myogenic cells in vitro. These findings suggest that the mechanism leading to the increased accumulation of iNOS in IBM might be triggered by the synergistic effects of Aβ and IFN-γ. This study also provides a useful in vitro experimental system to further investigate the potential role of oxidative stress driven by Aβ deposition in the pathogenesis of muscle tissue damage in IBM.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>Oxford University Press 2000 in significant NO 2 -release into cell-free supernatants. Northern blot analysis of RNA obtained from Aβ/IFN-γstimulated C2C12 cells revealed increased mRNA accumulation of inducible nitric oxide synthase (iNOS). Moreover, ~4% of muscle cells incubated with Aβ peptides and IFN-γ showed ultrastructural features of DNA fragmentation. These findings, taken together, indicate that the association of Aβ with IFN-γ stimulates NO 2 production via induction of iNOS gene expression in skeletal muscle cells, with occasional evidence for nuclear changes suggesting apoptotic morphology. These data further support a role for Aβ deposition in the pathogenesis of postulated oxidative damage in IBM.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1</head><label>1</label><figDesc>Fig. 1 Effect of Aβ peptides and IFN-γ on NO 2 -production by C2C12 cells. C2C12 cells were cultured in 96-well plates and stimulated with Aβ[25-35] or Aβ[1-42] 50 µg/ml in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of five performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2</head><label>2</label><figDesc>Fig. 2 Dose-response effect of Aβ peptides plus IFN-γ on NO 2-production by C2C12 cells. C2C12 cells were cultured in 96-well plates and stimulated with increasing concentrations of Aβ[25][26][27][28][29][30][31][32][33][34][35] or Aβ in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of three performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3</head><label>3</label><figDesc>Fig. 3 Comparison of and scrambled on NO 2 -production by C2C12 cells. C2C12 cells were cultured in 96-well plates and stimulated with or Aβ[25][26][27][28][29][30][31][32][33][34][35] scrambled 50 µg/ml in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of three performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4</head><label>4</label><figDesc>Fig. 4 Effect of plus IFN-γ on NO 2 -production by C2C12 myoblasts and myotubes. C2C12 myoblasts and myotubes were cultured in 96-well plates and stimulated with Aβ[1-42] 50 µg/ml in the presence or absence of IFN-γ 100 U/ml. After 48 h of incubation, supernatants were harvested and assayed for NO 2 -accumulation. The figure depicts a representative experiment out of three performed with similar results. Mean values Ϯ standard deviations of assays performed with supernatants collected from triplicate wells for each condition are shown.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 5</head><label>5</label><figDesc>Fig.5Effect of Aβ peptides plus IFN-γ on iNOS mRNA expression in C2C12 cells. C2C12 cells, cultured in six-well plates, were stimulated for 4 h with or Aβ[1-42] 50 µg/ml in the presence or absence of IFN-γ 100 U/ml. Total RNA was purified and analysed by Northern blot analysis. Hybridizations with iNOS and G3PDH cDNAs are shown for a representative experiment out of two performed with similar results.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 6</head><label>6</label><figDesc>Fig. 6 Apoptotic features in C2C12 cells treated with Aβ[1-42] and IFN-γ for 48 h. (A) A muscle cell (arrow) shows nuclear fragmentation, as revealed by DAPI staining (magnification ϫ1000). (B) Electron micrograph of a myotube showing an apoptotic nucleus (Nu) with irregular clusters of condensed chromatin. A normal nucleus (*) and preserved cytoplasm (cy) are also visible (magnification ϫ12 000).</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>This work was supported by Associazione Amici del Centro Dino Ferrari, and by a grant from IRCCS Ospedale Maggiore Policlinico (Progetto a Concorso Ricerca Corrente anno 1993), Milan, Italy.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">New advances in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">β-amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Glenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page" from="560" to="561" />
			<date type="published" when="1992">1992a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abormalities in cultured normal human muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1314" to="1319" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">β-APP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´s</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Nitric oxide release is present from incubated skeletal muscle preparations</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Balon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Nadler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="2519" to="2521" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Blough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Zafiriou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inorg Chem</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="3504" to="3505" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Free radicals, programmed cell death and muscular dystrophy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="373" to="378" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Nitric oxide: actions and pathological roles</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroscientist</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="9" to="20" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Gases as biological messengers: nitric oxide and carbon monoxide in the brain</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Snyder</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="5147" to="5149" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: pathologic changes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Figarella-Branger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baeta-Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Putzu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Pellissier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Inclusion-body myositis and myopathies</title>
				<editor>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</editor>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="1998">1998</date>
			<biblScope unit="page" from="137" to="155" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase isoenzymes: characterization, purification, molecular cloning, and functions</title>
		<author>
			<persName><forename type="first">U</forename><surname>Forstermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Closs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1121" to="1131" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Alzheimer&apos;s disease and prion proteins: a meeting made in muscle</title>
		<author>
			<persName><forename type="first">P</forename><surname>Gambetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perry</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1261" to="1264" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Evidence of neuronal oxidative damage in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Good</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Olanow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Perl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="21" to="28" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Uemura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Cunnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">692</biblScope>
			<biblScope unit="page" from="207" to="214" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hockenbery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nunez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Milliman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Korsmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="334" to="336" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Pathology of the inflammatory myopathies</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bailliere&apos;s clinical neurology</title>
		<editor>Mastaglia FL</editor>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="527" to="556" />
			<date type="published" when="1993">1993</date>
			<publisher>Bailliere Tindall</publisher>
		</imprint>
	</monogr>
	<note>Inflammatory myopathies</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Nitric oxide in skeletal muscle [letter]</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kobzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Bredt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Stamler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="546" to="548" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Orloff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="6370" to="6374" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of β-amyloidosis in Alzheimer&apos;s disease and other cerebral amyloidosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Maury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="4" to="16" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Priming of monocyte respiratory burst by β-amyloid fragment</title>
		<author>
			<persName><forename type="first">L</forename><surname>Meda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bonaiuto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Otvos</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cassatella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">219</biblScope>
			<biblScope unit="page" from="91" to="94" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Activation of microglial cells by β-amyloid protein and interferon-γ</title>
		<author>
			<persName><forename type="first">L</forename><surname>Meda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cassatella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Szendrei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Otvos</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Villalba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page" from="647" to="650" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Myology</title>
				<editor>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Franzini-Armstrong</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>McGraw-Hill</publisher>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page" from="1384" to="1398" />
		</imprint>
	</monogr>
	<note>2nd ed</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Ultrastructural localization of calcium binding sites on human muscle cell surface</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jann</forename><forename type="middle">S</forename><surname>Adobbati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Prelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gallanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fagiolari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="910" to="914" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Regulation of biosynthesis of nitric oxide</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">W</forename><surname>Xie</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="13725" to="13728" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Rockett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Awburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Aggarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Cowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="3725" to="3730" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Expression of β-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="27" to="33" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Widespread peroxynitrite-mediated damage in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Richey</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="2653" to="2657" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD-and FMN-containing flavoprotein</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stuehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Weise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Nathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="7773" to="7777" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Cytokineinduced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Prager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Giroir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="R1020" to="1025" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle</title>
		<author>
			<persName><forename type="first">D</forename><surname>Yaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Saxel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="725" to="727" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1089" to="1097" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">Second revision</title>
		<imprint>
			<date type="published" when="1999-01-07">January 7, 1999. May 26. 1999. September 13. 1999. September 13. 1999</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
